THOMAS I H DUBIN Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
Get free email notifications about insider trading for THOMAS I H DUBIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS I H DUBIN. THOMAS I H DUBIN is SVP & Chief Legal Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP & General Counsel in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP and Chief Legal Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP and General Counsel in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Chief Legal Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and Vice Pres. & General Counsel in ALEXION PHARMACEUTICALS INC ($ALXN) and Vice President & Gen. Counsel in ALEXION PHARMACEUTICALS INC ($ALXN) and VP & General Counsel in ALEXION PHARMACEUTICALS INC ($ALXN).
THOMAS I H DUBIN in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THOMAS I H DUBIN: SVP and Chief Legal Officer, SVP, Chief Legal Officer, SVP & Chief Legal Officer, SVP and General Counsel, SVP & General Counsel, VP & General Counsel, Vice President & Gen. Counsel, Vice Pres. & General Counsel
Holdings: 65,705 shares
Current Value: $8,391,843
Latest Transaction: Aug 27 2012
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of THOMAS I H DUBIN in ALEXION PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 27 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 103.87 | 9,200 | 955,604 | 65,705 | 74.9 K to 65.7 K (-12.28 %) |
Aug 27 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 103.09 | 24,328 | 2,507,974 | 74,905 | 99.2 K to 74.9 K (-24.52 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 78.88 | 4,000 | 315,520 | 60,000 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 42.66 | 28,124 | 1,199,770 | 61,876 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 22.90 | 56,250 | 1,288,125 | 43,750 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 17.98 | 82,671 | 1,486,425 | 12,751 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 104.94 | 680 | 71,359 | 99,233 | 99.9 K to 99.2 K (-0.68 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 106.14 | 668 | 70,902 | 99,913 | 100.6 K to 99.9 K (-0.66 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 109.28 | 28,200 | 3,081,696 | 100,581 | 128.8 K to 100.6 K (-21.90 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 108.56 | 68,632 | 7,450,690 | 128,781 | 197.4 K to 128.8 K (-34.77 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 107.57 | 51,303 | 5,518,664 | 197,413 | 248.7 K to 197.4 K (-20.63 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 106.35 | 16,642 | 1,769,877 | 248,716 | 265.4 K to 248.7 K (-6.27 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 105.76 | 6,268 | 662,904 | 265,358 | 271.6 K to 265.4 K (-2.31 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 78.88 | 4,000 | 315,520 | 271,626 | 267.6 K to 271.6 K (+1.49 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 42.66 | 28,124 | 1,199,770 | 267,626 | 239.5 K to 267.6 K (+11.74 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 22.90 | 56,250 | 1,288,125 | 239,502 | 183.3 K to 239.5 K (+30.70 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.98 | 82,671 | 1,486,425 | 183,252 | 100.6 K to 183.3 K (+82.19 %) |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 17.98 | 6,578 | 118,272 | 95,422 | |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 17.65 | 36,000 | 635,400 | 0 | |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 94.04 | 9,011 | 847,394 | 100,581 | 109.6 K to 100.6 K (-8.22 %) |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 93.96 | 33,567 | 3,153,955 | 109,591 | 143.2 K to 109.6 K (-23.45 %) |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.98 | 6,578 | 118,272 | 143,159 | 136.6 K to 143.2 K (+4.82 %) |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.65 | 36,000 | 635,400 | 136,581 | 100.6 K to 136.6 K (+35.79 %) |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Option Exercise | M | 17.65 | 39,000 | 688,253 | 36,000 | |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Option Exercise | M | 11.92 | 44,308 | 527,930 | 0 | |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Option Exercise | M | 10.29 | 20,092 | 206,696 | 0 | |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Sell | S | 92.02 | 103,400 | 9,514,485 | 100,581 | 204 K to 100.6 K (-50.69 %) |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Buy | M | 17.65 | 39,000 | 688,253 | 203,981 | 165 K to 204 K (+23.64 %) |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Buy | M | 11.92 | 44,308 | 527,930 | 164,981 | 120.7 K to 165 K (+36.72 %) |
May 31 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and Chief Legal ... | Buy | M | 10.29 | 20,092 | 206,696 | 120,673 | 100.6 K to 120.7 K (+19.98 %) |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 8.18 | 18,088 | 147,960 | 0 | |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 17.65 | 5,000 | 88,250 | 0 | |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 11.92 | 5,692 | 67,849 | 0 | |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 10.29 | 9,908 | 101,953 | 0 | |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 8.18 | 18,088 | 147,960 | 100,581 | 82.5 K to 100.6 K (+21.93 %) |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.65 | 5,000 | 88,250 | 82,493 | 77.5 K to 82.5 K (+6.45 %) |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 11.92 | 5,692 | 67,849 | 77,493 | 71.8 K to 77.5 K (+7.93 %) |
May 14 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 10.29 | 9,908 | 101,953 | 71,931 | 62 K to 71.9 K (+15.97 %) |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 10.29 | 20,000 | 205,800 | 20,092 | |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 8.18 | 21,912 | 179,240 | 0 | |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 6.90 | 24,000 | 165,600 | 0 | |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 89.24 | 11,200 | 999,488 | 62,023 | 73.2 K to 62 K (-15.30 %) |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 88.72 | 54,712 | 4,854,049 | 73,233 | 127.9 K to 73.2 K (-42.76 %) |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 10.29 | 20,000 | 205,800 | 127,935 | 107.9 K to 127.9 K (+18.53 %) |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 8.18 | 21,912 | 179,240 | 107,935 | 86 K to 107.9 K (+25.47 %) |
Mar 16 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 6.90 | 24,000 | 165,600 | 86,023 | 62 K to 86 K (+38.70 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 5.18 | 32,000 | 165,760 | 0 | |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 5.10 | 40,000 | 204,000 | 0 | |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 83.84 | 5,000 | 419,200 | 62,023 | 67 K to 62 K (-7.46 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 83.45 | 84,871 | 7,082,485 | 67,023 | 151.9 K to 67 K (-55.88 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 5.18 | 32,000 | 165,760 | 151,894 | 119.9 K to 151.9 K (+26.69 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 5.10 | 40,000 | 204,000 | 119,894 | 79.9 K to 119.9 K (+50.07 %) |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 78.88 | 64,000 | 5,048,320 | 64,000 | |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 0.00 | 8,000 | 0 | 79,894 | 71.9 K to 79.9 K (+11.13 %) |
Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 74.51 | 2,002 | 149,169 | 71,894 | 73.9 K to 71.9 K (-2.71 %) |
Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 74.41 | 663 | 49,334 | 73,896 | 74.6 K to 73.9 K (-0.89 %) |
Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 75.00 | 562 | 42,150 | 74,559 | 75.1 K to 74.6 K (-0.75 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 5.10 | 16,500 | 84,150 | 0 | |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 5.82 | 22,460 | 130,717 | 0 | |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 69.70 | 38,960 | 2,715,512 | 75,121 | 114.1 K to 75.1 K (-34.15 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 5.10 | 16,500 | 84,150 | 114,081 | 97.6 K to 114.1 K (+16.91 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 5.82 | 22,460 | 130,717 | 97,581 | 75.1 K to 97.6 K (+29.90 %) |
Aug 24 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 5.10 | 7,500 | 38,250 | 0 | |
Aug 24 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 4.03 | 8,488 | 34,207 | 0 | |
Aug 24 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 5.82 | 17,540 | 102,083 | 0 | |
Aug 24 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 5.10 | 7,500 | 38,250 | 75,121 | 67.6 K to 75.1 K (+11.09 %) |
Aug 24 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 4.03 | 8,488 | 34,207 | 67,621 | 59.1 K to 67.6 K (+14.35 %) |
Aug 24 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 5.82 | 17,540 | 102,083 | 59,133 | 41.6 K to 59.1 K (+42.17 %) |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | M | 4.03 | 31,512 | 126,993 | 0 | |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 57.27 | 669 | 38,314 | 41,593 | 42.3 K to 41.6 K (-1.58 %) |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 58.48 | 31,512 | 1,842,822 | 42,262 | 73.8 K to 42.3 K (-42.71 %) |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 4.03 | 31,512 | 126,993 | 73,774 | 42.3 K to 73.8 K (+74.56 %) |
Jul 12 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 50.00 | 501 | 25,050 | 42,262 | 42.8 K to 42.3 K (-1.17 %) |
Mar 03 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 99.27 | 4,310 | 427,854 | 21,632 | 25.9 K to 21.6 K (-16.61 %) |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP, Chief Legal Of ... | Option Exercise | A | 85.31 | 45,000 | 3,838,950 | 45,000 | |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP, Chief Legal Of ... | Grant | A | 0.00 | 5,000 | 0 | 25,942 | 20.9 K to 25.9 K (+23.88 %) |
Jan 28 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 84.70 | 1,323 | 112,058 | 20,942 | 22.3 K to 20.9 K (-5.94 %) |
Jan 18 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 82.66 | 265 | 21,905 | 22,265 | 22.5 K to 22.3 K (-1.18 %) |
Jan 12 2011 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 81.27 | 280 | 22,756 | 22,530 | 22.8 K to 22.5 K (-1.23 %) |
Dec 01 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | S | 17.69 | 50,000 | 884,500 | 0 | |
Dec 01 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 75.83 | 6,045 | 458,392 | 22,810 | 28.9 K to 22.8 K (-20.95 %) |
Dec 01 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 75.12 | 43,955 | 3,301,900 | 28,855 | 72.8 K to 28.9 K (-60.37 %) |
Dec 01 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.69 | 50,000 | 884,500 | 72,810 | 22.8 K to 72.8 K (+219.20 %) |
Oct 28 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | S | 10.50 | 10 | 105 | 0 | |
Oct 28 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | S | 17.69 | 20,000 | 353,800 | 50,000 | |
Oct 28 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 67.79 | 20,010 | 1,356,478 | 22,810 | 42.8 K to 22.8 K (-46.73 %) |
Oct 28 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 10.50 | 10 | 105 | 42,820 | 42.8 K to 42.8 K (+0.02 %) |
Oct 28 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.69 | 20,000 | 353,800 | 42,810 | 22.8 K to 42.8 K (+87.68 %) |
Sep 03 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Option Exercise | S | 17.69 | 20,000 | 353,800 | 70,000 | |
Sep 03 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Sell | S | 58.14 | 20,000 | 1,162,800 | 9,934 | 29.9 K to 9.9 K (-66.81 %) |
Sep 03 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & Chief Legal O ... | Buy | M | 17.69 | 20,000 | 353,800 | 29,934 | 9.9 K to 29.9 K (+201.33 %) |
Jul 19 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 51.08 | 249 | 12,719 | 9,934 | 10.2 K to 9.9 K (-2.45 %) |
Jul 13 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 51.91 | 249 | 12,926 | 10,183 | 10.4 K to 10.2 K (-2.39 %) |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | A | 45.80 | 50,000 | 2,290,000 | 50,000 | |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Grant | A | 0.00 | 6,000 | 0 | 10,432 | 4.4 K to 10.4 K (+135.38 %) |
Jan 21 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 47.22 | 249 | 11,758 | 4,432 | 4.7 K to 4.4 K (-5.32 %) |
Jan 12 2010 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 47.68 | 1,382 | 65,894 | 4,681 | 6.1 K to 4.7 K (-22.79 %) |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | M | 10.50 | 51,990 | 545,895 | 0 | |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 42.75 | 58,044 | 2,481,381 | 6,063 | 64.1 K to 6.1 K (-90.54 %) |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Buy | M | 10.50 | 51,990 | 545,895 | 64,107 | 12.1 K to 64.1 K (+429.07 %) |
Jul 17 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 38.96 | 238 | 9,272 | 12,117 | 12.4 K to 12.1 K (-1.93 %) |
Jul 13 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 36.93 | 238 | 8,789 | 12,355 | 12.6 K to 12.4 K (-1.89 %) |
Jun 05 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 37.43 | 10,000 | 374,300 | 12,593 | 22.6 K to 12.6 K (-44.26 %) |
Mar 18 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 34.25 | 2,232 | 76,446 | 22,593 | 24.8 K to 22.6 K (-8.99 %) |
Mar 12 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 32.34 | 1,031 | 33,343 | 24,825 | 25.9 K to 24.8 K (-3.99 %) |
Jan 28 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | A | 35.95 | 51,000 | 1,833,450 | 51,000 | |
Jan 28 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Grant | A | 0.00 | 8,000 | 0 | 25,856 | 17.9 K to 25.9 K (+44.80 %) |
Jan 16 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 36.93 | 1,049 | 38,740 | 17,856 | 18.9 K to 17.9 K (-5.55 %) |
Jan 14 2009 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 34.48 | 282 | 9,723 | 18,905 | 19.2 K to 18.9 K (-1.47 %) |
Sep 12 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 40.12 | 1,031 | 41,364 | 19,187 | 20.2 K to 19.2 K (-5.10 %) |
Aug 08 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and General Cou ... | Gift | G | 0.00 | 65 | 0 | 10,109 | 10.2 K to 10.1 K (-0.64 %) |
Aug 08 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP and General Cou ... | Sell | S | 90.47 | 4,721 | 427,109 | 10,174 | 14.9 K to 10.2 K (-31.70 %) |
Jul 11 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 75.75 | 120 | 9,090 | 14,895 | 15 K to 14.9 K (-0.80 %) |
Mar 12 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 56.05 | 515 | 28,866 | 15,015 | 15.5 K to 15 K (-3.32 %) |
Jan 11 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | S | 70.59 | 20,000 | 1,411,800 | 20,000 | |
Jan 11 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 69.02 | 555 | 38,306 | 15,530 | 16.1 K to 15.5 K (-3.45 %) |
Jan 11 2008 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Grant | A | 0.00 | 3,000 | 0 | 16,085 | 13.1 K to 16.1 K (+22.93 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 75.21 | 600 | 45,126 | 13,085 | 13.7 K to 13.1 K (-4.38 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | S | 75.19 | 1,050 | 78,950 | 13,685 | 14.7 K to 13.7 K (-7.13 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.59 | 500 | 37,295 | 14,735 | 15.2 K to 14.7 K (-3.28 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.58 | 100 | 7,458 | 15,235 | 15.3 K to 15.2 K (-0.65 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.57 | 200 | 14,914 | 15,335 | 15.5 K to 15.3 K (-1.29 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.54 | 400 | 29,816 | 15,535 | 15.9 K to 15.5 K (-2.51 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.52 | 400 | 29,808 | 15,935 | 16.3 K to 15.9 K (-2.45 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.47 | 300 | 22,341 | 16,335 | 16.6 K to 16.3 K (-1.80 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.46 | 900 | 67,014 | 16,635 | 17.5 K to 16.6 K (-5.13 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.44 | 662 | 49,279 | 17,535 | 18.2 K to 17.5 K (-3.64 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.43 | 100 | 7,443 | 18,197 | 18.3 K to 18.2 K (-0.55 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.42 | 100 | 7,442 | 18,297 | 18.4 K to 18.3 K (-0.54 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.41 | 400 | 29,764 | 18,397 | 18.8 K to 18.4 K (-2.13 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.40 | 100 | 7,440 | 18,797 | 18.9 K to 18.8 K (-0.53 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.39 | 300 | 22,317 | 18,897 | 19.2 K to 18.9 K (-1.56 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.38 | 200 | 14,876 | 19,197 | 19.4 K to 19.2 K (-1.03 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.37 | 800 | 59,496 | 19,397 | 20.2 K to 19.4 K (-3.96 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.35 | 100 | 7,435 | 20,197 | 20.3 K to 20.2 K (-0.49 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.32 | 500 | 37,160 | 20,297 | 20.8 K to 20.3 K (-2.40 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.30 | 100 | 7,430 | 20,797 | 20.9 K to 20.8 K (-0.48 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.29 | 100 | 7,429 | 20,897 | 21 K to 20.9 K (-0.48 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.28 | 100 | 7,428 | 20,997 | 21.1 K to 21 K (-0.47 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.27 | 100 | 7,427 | 21,097 | 21.2 K to 21.1 K (-0.47 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.26 | 300 | 22,278 | 21,197 | 21.5 K to 21.2 K (-1.40 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | M | 17.67 | 5,625 | 99,394 | 0 | |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | M | 17.67 | 4,375 | 77,306 | 0 | |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | M | 10.74 | 6,875 | 73,838 | 0 | |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | M | 10.74 | 3,125 | 33,563 | 0 | |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.25 | 700 | 51,975 | 21,497 | 22.2 K to 21.5 K (-3.15 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.24 | 449 | 33,334 | 22,197 | 22.6 K to 22.2 K (-1.98 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.23 | 479 | 35,556 | 22,646 | 23.1 K to 22.6 K (-2.07 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.21 | 500 | 37,105 | 23,125 | 23.6 K to 23.1 K (-2.12 %) |
Nov 29 2007 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Sell | M | 74.20 | 500 | 37,100 | 23,625 | 24.1 K to 23.6 K (-2.07 %) |